Table 4 |
|||||
|
The identified synoviocyte proteins increased by neutrophil gelatinase-associated lipocalin (NGAL) |
|||||
| Spot no. |
Ratio (treated/untreated) |
MW (kDa)/pI (observed) |
Protein |
MW (kDa)/pI (calculated) |
Accession no. (Swiss-Prot) |
|
|
|||||
| 497 |
4.8 |
93.3/5.4 |
Transitional endoplasmic reticulum ATPase |
89.0/5.1 |
[Swiss-Prot:P55072] |
| 451 |
1.6 |
95.0/5.5 |
Actinin 4 |
104.8/5.3 |
[Swiss-Prot:O43707] |
| 540 |
1.6 |
91.0/5.4 |
Transglutaminase 2 |
77.3/5.1 |
[Swiss-Prot:P21980] |
| 2,217 |
1.5 |
29.5/5.6 |
Cathepsin D |
44.5/6.1 |
[Swiss-Prot:P07339] |
| 1,004 |
1.6 |
67.6/6.4 |
T-complex protein 1 subunit β |
57.3/6.0 |
[Swiss-Prot:P78371] |
| 1,877 |
1.6 |
38.9/5.7 |
Dimethylargininase-2 |
38.9/5.7 |
[Swiss-Prot:O95865] |
| 2,135 |
1.6 |
32.9/5.4 |
Prohibitin |
29.8/5.6 |
[Swiss-Prot:P35232] |
| 2,344 |
1.8 |
28.0/5.9 |
Endoplasmic reticulum protein 29 |
28.0/5.9 |
[Swiss-Prot:P30040] |
| 2,857 |
1.5 |
18.4/6.0 |
Nucleoside diphosphate kinase A |
17.1/5.8 |
[Swiss-Prot:P15531] |
|
|
|||||
|
Katano et al. Arthritis Research & Therapy 2009 11:R3 doi:10.1186/ar2587 |
|||||
